angiotensin ii has been researched along with eflornithine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altiere, RJ; Dyer, KK; Gillespie, MN; O'Connor, WN; Olson, JW | 1 |
Hughes, AD; Ibrahim, J; Schachter, M; Sever, PS | 1 |
Adams, MA; Friberg, P; Isgaard, J; Wåhlander, A; Wickman, A | 1 |
3 other study(ies) available for angiotensin ii and eflornithine
Article | Year |
---|---|
alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Topics: Angiotensin II; Animals; Blood Pressure; Eflornithine; Enzyme Activation; In Vitro Techniques; Lung; Male; Monocrotaline; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Potassium Chloride; Pulmonary Artery; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Vasoconstriction | 1985 |
Depletion of resistance vessel polyamines attenuates angiotensin II induced blood pressure rise in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Eflornithine; Enzyme Inhibitors; In Vitro Techniques; Male; Mesenteric Arteries; Ornithine Decarboxylase Inhibitors; Polyamines; Rats; Rats, Inbred WKY | 1996 |
Inhibited expression of insulin-like growth factor I mRNA and attenuated cardiac hypertrophy in volume overloaded hearts treated with difluoromethylornithine.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Eflornithine; Gene Expression Regulation; Hypertrophy, Right Ventricular; Insulin-Like Growth Factor I; Male; Organ Size; Ornithine Decarboxylase Inhibitors; Rats; Rats, Wistar; RNA, Messenger | 1998 |